Opioid Use Disorder Market 2024 [Latest Trends]: Analysis Future Opportunity and Demand Forecast Year 2030

The Latest Research Report on Opioid Use Disorder Market 2024 outlines the key factors influencing the growth of this area in terms of the competitive and geographic environment. In addition, the research discusses the obstacles to market growth and provides information on unexplored prospects that will promote company progress in the 2024-2030 forecast period.

Get a sample PDF of the report in your inbox within 24 hours: https://www.cognatelifesciences.com/sample-request/2114/

Major Major Players are:
Players 1, Players 2, Players 3 and More.

Opioid Use Disorder Market Overview:

Opioid Use Disorder Market Overview (2024 - 2030)

The global market for Opioid Use Disorder (OUD) was valued at an estimated USD 3.21 billion in 2023 and is anticipated to achieve a valuation of USD 6.54 billion by 2030, registering a Compound Annual Growth Rate (CAGR) of 10.7% throughout the forecast period spanning 2024 to 2030.

OPIOID USE DISORDER

Opioids, designed for pain management, exhibit adverse effects on the central nervous system and analgesic functions, often leading to euphoria. Opioid use disorder manifests as a chronic, recurring condition associated with significantly elevated morbidity and mortality rates. The market's trajectory is propelled by the escalating number of individuals grappling with opioid-related addictions, augmented governmental initiatives, and heightened support from non-governmental organizations (NGOs) and agencies. Nevertheless, impediments such as individuals' reluctance to pursue treatment modalities and the discontinuation of behavioral treatments leading to relapse act as constraints to market growth. Governmental programs and funding play pivotal roles in sustaining this industry.

Key Market Insights:

Orexo AB has entered into a collaboration with ApexB.io and Magellan Rx Management to explore the utilization of Modia, a digital therapy tailored for individuals with Opioid Use Disorder (OUD). Modia facilitates personalized, interactive psychotherapy sessions accessible to individuals with OUD via their computer or mobile devices.

The acquisition of Opiant Pharmaceuticals, Inc. by Indivior PLC has been successfully concluded, enhancing Indivior's position in the addiction therapy domain, particularly with the investigational opioid overdose therapy candidate OPNT003.

Global Opioid Use Disorder Market Drivers:

Growing Recognition of Buprenorphine Patches as a Successful Treatment Approach to Drive Market Expansion:

There is a growing demand for patches addressing opioid addiction, recognized as an effective therapeutic for opioid use disorder. Transdermal patches, offering benefits such as self-administration and improved medication administration mechanisms, are gaining acceptance. Collaborations, such as the one between WellSpan Health and York Opioid Collaborative in 2009, are anticipated to accelerate therapy acceptance, with a projected influx of new patients driving global market expansion.

Increasing Cases of Opioid Addiction to Increase Market Share:

The global prevalence of severe and chronic illnesses, leading to opioid use for pain management, contributes to the rise in opioid addiction cases. The growing frequency of Opioid Use Disorder (OUD) globally, as evidenced by reports such as the CDC's estimation of 2.7 million individuals aged 12 or older with OUD in the United States in 2021, presents a significant market expansion opportunity.

Global Opioid Use Disorder Market Challenges:

Adverse OUD Drug Effects to Limit Market Growth:

Challenges are anticipated due to the negative effects associated with medications treating opioid addiction, including muscular pains, nausea, respiratory issues, and psychological concerns. Regulatory warnings, such as the U.S. FDA's cautionary statement on dental issues linked to buprenorphine, might hinder market growth to some extent.

Global Opioid Use Disorder Market Opportunities:

Governmental and non-governmental organizations emphasizing awareness campaigns represent a key opportunity for industry growth. The increased involvement of such organizations, exemplified by initiatives like Health and Human Services' funding for drug abuse prevention and treatment, is expected to encourage individuals with opioid-related issues to seek treatment, thus benefiting the global market in the foreseeable future.

Get a Impressive Discount on corporate email id @ https://www.cognatelifesciences.com/discount-request/2114/

Market Segmentation are:
Segmented By Drug (Buprenorphine [Sublocade, Belbuca, Suboxone, Zubsolv], Methadone, Naltrexone), By Route of Administration (Intravenous, Oral), By Age (19 to 40, 41 to 60, and 61 & over) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies); and Region- Size, Share, Growth Analysis | Forecast (2024 2030)

Opioid Use Disorder insights, overview and deep study of factors are considered to have greater influence over future course of the industry such as market size, market share, different dynamics of the industry, Opioid Use Disorder market companies, regional analysis of the domestic markets, value chain analysis, consumption, demand, key application areas and more.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

How will this report benefit potential stakeholders?
-Comprehensive assessment of all opportunities and risks in the Opioid Use Disorder market.
-The detailed study of business strategies for the growth of the Opioid Use Disorder market-leading players.
-Conclusive study about the growth plot of the Opioid Use Disorder market for forthcoming years.
-In-depth understanding of Opioid Use Disorder market-particular drivers, constraints, and major micro markets.
-Favorable impression inside vital technological and market latest trends striking the Opioid Use Disorder market.

Any Questions? Feel Free To Enquire Here. Well put you on the Right Path @ https://www.cognatelifesciences.com/enquiry-request/2114/

What Opioid Use Disorder Market report offers:
1.Opioid Use Disorder Market share assessments for the regional and country-level segments
2.Market share analysis of the top industry players
3.Opioid Use Disorder Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
4.Strategic recommendations in key business segments based on the market estimations
5.Competitive landscape covering following points: Company Overview, Product Portfolio, Financial Performance, Recent Highlights, Strategies

COVID-19 has had a major impact on the world economy in addition to that on the public health. This particular pandemic had caused severe economic destruction and not a single country has been left unaffected. The virus has forced businesses around the globe to change the way they operate. This report gives an analysis of the COVID-19 aftermath on Opioid Use Disorder market.

Competitive Rivalry:
The report highlights vital details based on the leading players in the global Industrial Opioid Use Disorder market. It features their details such as product/business portfolio, market share, financial status, regional share, segment revenue, SWOT analysis, manufacturing base, capacities, production volume, major vendors, raw material sourcing strategies, organizational structure. Their latest corporate deals, joint ventures, mergers and acquisitions, product launches, and other brand promotions are other facts about the market players included in the report.

We also offer customization on reports based on specific client requirement:
1- country-level analysis for any 5 countries of your choice.
2- Competitive analysis of any market players.
3- 40 analyst hours to cover any other data points

Purchase this report now @ https://www.cognatelifesciences.com/buy-now/?id=2114&license_type=su

Finally, Opioid Use Disorder Market is a valuable source of guidance for individuals and companies in decision framework.

Contact Us:
Robin McKay
Client Partner Relations
USA/Canada(Toll Free): 1800-601-6071
Mail: sales@cognatelifesciences.com
Web: www.cognatelifesciences.com

About us :

Cognate Lifesciences is a specialized hub for all market research reports related to Lifesciences Market. Some of the sub domains covered by our team are Pharmaceuticals, Medical Devices and Supplies, Healthcare, Diagnostics, Biotech, Therapeutics, Healthcare IT etc. We offer syndicated/customized market research studies along with advisory and consulting services.

This release was published on openPR.